BRM Stock Price, Chart, Stats & News
Bristol-Myers Squibb Company (BRM) is a dividend-paying stock with a current dividend yield of 4.21% as of Jun 30, 2026. It pays 2,13 € per share over the trailing twelve months and distributes quarterly. Its dividend has grown at a 2.54% 5-year compound annual rate.
Dividend safety
Dividend coverage looks healthy — BRM pays out about 55% of earnings.
BRM chart
About
Bristol-Myers Squibb Company operates globally as a biopharmaceutical powerhouse, engaging in the research, development, licensing, manufacturing, and marketing of innovative health solutions. Its extensive product pipeline addresses critical conditions across various therapeutic areas, including hematology, oncology, cardiovascular health, immunology, fibrotic diseases, neuroscience, and COVID-19. Key offerings from the company include Revlimid, an oral immunomodulatory drug for treating multiple myeloma, and Eliquis, an oral inhibitor prescribed for reducing stroke risk in non-valvular atrial fibrillation and for managing deep vein thrombosis/pulmonary embolism.
Related lists
Similar securities
Based on sector and market capitalization
